Zacks Research Analysts Lower Earnings Estimates for Neogen

Neogen Co. (NASDAQ:NEOG - Free Report) - Research analysts at Zacks Research decreased their FY2025 EPS estimates for Neogen in a research report issued on Wednesday, February 12th. Zacks Research analyst R. Department now expects that the company will earn $0.38 per share for the year, down from their previous estimate of $0.39. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen's FY2026 earnings at $0.50 EPS and FY2027 earnings at $0.57 EPS.

A number of other brokerages have also issued reports on NEOG. Piper Sandler reiterated a "neutral" rating and set a $13.00 target price (down from $16.50) on shares of Neogen in a research report on Tuesday, January 21st. Guggenheim started coverage on shares of Neogen in a research report on Thursday, December 19th. They set a "buy" rating and a $15.00 target price on the stock.

Neogen Price Performance

Neogen stock traded up $0.56 during trading hours on Friday, hitting $10.39. 2,681,259 shares of the stock were exchanged, compared to its average volume of 2,766,844. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.46 and a current ratio of 3.77. The stock has a market capitalization of $2.25 billion, a P/E ratio of -4.74 and a beta of 1.23. Neogen has a 12 month low of $9.70 and a 12 month high of $18.58. The business's 50-day moving average is $11.66 and its two-hundred day moving average is $14.08.

Neogen (NASDAQ:NEOG - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.12. The firm had revenue of $231.30 million for the quarter, compared to analysts' expectations of $227.16 million. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The company's quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.11 earnings per share.

Insider Transactions at Neogen

In other Neogen news, CFO David H. Naemura acquired 14,800 shares of the business's stock in a transaction that occurred on Thursday, January 16th. The shares were acquired at an average cost of $11.11 per share, for a total transaction of $164,428.00. Following the completion of the acquisition, the chief financial officer now directly owns 61,434 shares of the company's stock, valued at approximately $682,531.74. This represents a 31.74 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John Edward Adent bought 23,035 shares of the business's stock in a transaction on Thursday, January 16th. The stock was purchased at an average price of $11.03 per share, for a total transaction of $254,076.05. Following the completion of the acquisition, the chief executive officer now owns 269,164 shares of the company's stock, valued at approximately $2,968,878.92. This trade represents a 9.36 % increase in their position. The disclosure for this purchase can be found here. 1.13% of the stock is owned by company insiders.

Institutional Investors Weigh In On Neogen

Several hedge funds have recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Neogen by 8.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 549,639 shares of the company's stock worth $6,673,000 after purchasing an additional 43,621 shares during the period. Squarepoint Ops LLC acquired a new stake in Neogen in the fourth quarter worth $840,000. State of Wyoming raised its holdings in Neogen by 6.3% in the fourth quarter. State of Wyoming now owns 47,775 shares of the company's stock worth $580,000 after purchasing an additional 2,846 shares during the period. Shapiro Capital Management LLC raised its holdings in Neogen by 47.9% in the fourth quarter. Shapiro Capital Management LLC now owns 2,932,850 shares of the company's stock worth $35,605,000 after purchasing an additional 949,300 shares during the period. Finally, Silvercrest Asset Management Group LLC raised its holdings in Neogen by 4.0% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 1,371,528 shares of the company's stock worth $16,650,000 after purchasing an additional 52,124 shares during the period. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.